Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aeglea BioTherapeutics, Inc. AGLE

Set alert

Price alert · AGLE

All alert types
12.01 +12.01 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
48.63M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-6.53
Beta
2.57
Short ratio
3.68
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2023
50-d avg
12.64
200-d avg
9.84
1y target
17.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for AGLE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.37 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -9.7×
FY 2015: -9.9×FY 2016: -2.0×FY 2017: -3.0×FY 2018: -3.5×FY 2019: -3.2×FY 2020: -5.2×FY 2021: -4.7×FY 2022: -0.5×FY 2024: -34.5×FY 2025: -9.7×
FY 2015 5y median -5.2× FY 2025
P/S 0.0×
FY 2015: 18.4×FY 2016: 9.2×FY 2017: 15.7×FY 2018: 40.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 16.7×FY 2022: 16.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
P/B 9.3×
FY 2015: 3.1×FY 2016: 0.7×FY 2017: 1.6×FY 2018: 2.3×FY 2019: 4.1×FY 2020: 3.0×FY 2021: 3.7×FY 2022: 0.8×FY 2024: 14.0×FY 2025: 9.3×
FY 2015 5y median 3.7× FY 2025
P/FCF -39.5×
FY 2015: -10.0×FY 2016: -2.2×FY 2017: -3.2×FY 2018: -4.8×FY 2019: -3.6×FY 2020: -5.2×FY 2021: -5.8×FY 2022: -0.5×FY 2024: -45.9×FY 2025: -39.5×
FY 2015 5y median -5.8× FY 2025
EV/EBITDA -42.5×
FY 2015: -7.3×FY 2016: 0.2×FY 2017: -2.5×FY 2018: -3.0×FY 2019: -2.9×FY 2020: -4.2×FY 2021: -4.6×FY 2022: -0.1×FY 2024: -34.2×FY 2025: -42.5×
FY 2015 5y median -4.6× FY 2025
EV/Sales 0.0×
FY 2015: 13.5×FY 2016: -1.1×FY 2017: 13.3×FY 2018: 34.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 16.1×FY 2022: 3.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
FCF Yield -2.5%
FY 2015: -10.0%FY 2016: -44.7%FY 2017: -30.8%FY 2018: -20.9%FY 2019: -27.5%FY 2020: -19.1%FY 2021: -17.4%FY 2022: -211.4%FY 2024: -2.2%FY 2025: -2.5%
FY 2015 5y median -17.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2015: 100.0%FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2015: -185.9%FY 2016: -473.3%FY 2017: -531.7%FY 2018: -1169.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -350.3%FY 2022: -3640.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2015: -185.6%FY 2016: -468.8%FY 2017: -523.3%FY 2018: -1140.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -351.1%FY 2022: -3598.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
ROE -21.7%
FY 2015: -31.3%FY 2016: -34.5%FY 2017: -54.1%FY 2018: -65.8%FY 2019: -126.0%FY 2020: -57.4%FY 2021: -78.4%FY 2022: -166.6%FY 2024: -40.2%FY 2025: -21.7%
FY 2015 5y median -57.4% FY 2025
ROIC -29.1%
FY 2015: -31.3%FY 2016: -32.5%FY 2017: -48.5%FY 2018: -67.3%FY 2019: -119.2%FY 2020: -55.6%FY 2021: -72.8%FY 2022: -148.2%FY 2024: -37.6%FY 2025: -29.1%
FY 2015 5y median -55.6% FY 2025
ROA -20.0%
FY 2015: -29.2%FY 2016: -32.4%FY 2017: -48.6%FY 2018: -57.0%FY 2019: -91.0%FY 2020: -49.7%FY 2021: -59.9%FY 2022: -117.8%FY 2024: -34.2%FY 2025: -20.0%
FY 2015 5y median -49.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2015: 0.0%FY 2016: -23.9%FY 2017: 12.5%FY 2018: -25.3%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -87.6%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 FY 2025
Operating Income -0.5%
FY 2015: -27.1%FY 2016: -93.6%FY 2017: -26.3%FY 2018: -64.3%FY 2019: -76.7%FY 2020: -1.4%FY 2021: 19.4%FY 2022: -29.1%FY 2024: 0.0%FY 2025: -0.5%
FY 2015 FY 2025
EPS (diluted) -253.6%
FY 2015: 34.9%FY 2016: -124.2%FY 2017: 18.8%FY 2018: -18.3%FY 2019: -11.2%FY 2020: 36.5%FY 2021: 33.5%FY 2022: 0.6%FY 2024: 0.0%FY 2025: -253.6%
FY 2015 FY 2025
Free Cash Flow -7.5%
FY 2015: -48.9%FY 2016: -70.3%FY 2017: -32.4%FY 2018: -29.3%FY 2019: -106.0%FY 2020: -19.2%FY 2021: 32.2%FY 2022: -47.7%FY 2024: 0.0%FY 2025: -7.5%
FY 2015 FY 2025

Financial Health

Current Ratio 13.3×
FY 2015: 15.2×FY 2016: 16.8×FY 2017: 9.8×FY 2018: 7.5×FY 2019: 4.1×FY 2020: 9.1×FY 2021: 4.9×FY 2022: 4.2×FY 2024: 11.3×FY 2025: 13.3×
FY 2015 5y median 9.1× FY 2025
Quick Ratio 13.3×
FY 2015: 15.2×FY 2016: 16.8×FY 2017: 9.8×FY 2018: 7.5×FY 2019: 4.1×FY 2020: 9.1×FY 2021: 4.9×FY 2022: 4.2×FY 2024: 11.3×FY 2025: 13.3×
FY 2015 5y median 9.1× FY 2025
Debt / Equity 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2015: 2.6×FY 2016: 2.2×FY 2017: 0.5×FY 2018: 0.5×FY 2019: 0.2×FY 2020: 1.1×FY 2021: 0.2×FY 2022: 0.4×FY 2024: 0.4×FY 2025: 0.6×
FY 2015 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -101×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31